XML 123 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Beginning balance $ 178 $ (14,055) $ (26,456)
Realized and unrealized gains (losses):      
Included in regulatory assets (1,044) 0 12,402
Included in regulatory liability 0 14,234 0
Included in other comprehensive income 0 0 0
Included in earnings [1] 14,140 5,521 (6,439)
Included in current assets 118 237 (87)
Purchases 11,997 26,287 22,232
Sales 0 0 0
Issuances 0 0 0
Settlements (26,255) (32,046) (15,707)
Ending balance $ (866) $ 178 $ (14,055)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.